Physician profile
Harold Frank
NPI 1851405989
$3,090.97
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $578 · 2022: $1,792 · 2023: $703 · 2024: $17.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,400.31 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $356.79 | 2021-2023 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $314.57 | 2021-2023 | Relistor |
| Relievant Medsystems, INC. | $269.01 | 2023 | Intracept |
| Scilex Pharmaceuticals INC. | $204.98 | 2021-2023 | Ztlido |
| Tersera Therapeutics LLC | $105.84 | 2022-2023 | Prialt |
| Painteq LLC | $95.67 | 2021-2024 | Painteq |
| Vertos Medical, INC. | $77.16 | 2021-2022 | |
| Novo Nordisk INC | $45.81 | 2022 | |
| Abbvie INC. | $45.18 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $29.55 | 2021 | |
| Eisai INC. | $24.34 | 2021 | |
| Horizon Therapeutics Plc | $23.63 | 2022 | |
| Si-Bone, INC. | $21.62 | 2022 | |
| Indivior INC. | $19.12 | 2023 | Sublocade |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $16.85 | 2021 | |
| Stimwave Technologies Incorporated | $14.71 | 2021 | |
| Almatica Pharma LLC | $12.94 | 2021 | |
| Idorsia Pharmaceuticals US INC | $12.89 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.